GGrantIndex
Sort

64,565 grants matching “drug discovery”

Development of TGF-beta antagonists for cancer therapy

$817,677
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Engineering Multifunctional Nanoparticles

$817,618
Sangeeta N. Bhatia · Massachusetts Institute Of Technology · R01 · FY2008 · CA

Development of small molecule inhibitors of metabolic enzymes as broad spectrum anthelmintic drugs

$817,605
Makedonka Mitreva · Washington University · R01 · FY2021 · AI

Thiol redox signaling in aortic aneurysm

$817,498
Francesca Seta · Boston University Medical Campus · R01 · FY2025 · HL

TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimer’s Disease

$817,408
Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · AG

Establishment and Characterization of Novel Mutant Mouse Models for the Addiction Research Community

$817,399
Vivek Kumar · Jackson Laboratory · U01 · FY2022 · DA

Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma

$817,202
James M Olson · Seattle Children'S Hospital · U01 · FY2024 · CA

A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution

$817,050
Robin Prince · Fluid Discovery Inc · R42 · FY2023 · GM

Identification of neutralizing epitopes on SARS-CoV-2 spike for design of vaccines and small-molecule antivirals

$816,869
Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2020 · AI

Pharmacogenomics of HIV Therapy

$816,720
David W Haas · Vanderbilt University Medical Center · R01 · FY2023 · AI

Broad Spectrum Bitter Taste Antagonists Discovery

$816,655
Erik Mills Schwiebert · Discoverybiomed, Inc. · R42 · FY2020 · DC

Bridging pharmacodynamic biomarkers to clinical outcomes in pediatric inflammatory diseases

$816,558
John N Van Den Anker · Children'S Research Institute · P50 · FY2020 · HD

Topical Microbicides for Prevention of STDs/HIV

$816,472
Magee-Women'S Res Inst And Foundation · P01 · FY2001 · AI

Subtype-Selective Metabotropic Glutamate Receptor PET Ligands

$816,387
Steven H Liang · Emory University · R61 · FY2023 · NS

Structure-based microbially targeted prodrugs

$816,384
Audrey Ragan Odom John · Children'S Hosp Of Philadelphia · R01 · FY2023 · AI

Discovery of Natural Products and Natural Product-Like Inhibitors

$816,377
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors

$816,270
Elizabeth Phillips · Vanderbilt University Medical Center · R01 · FY2021 · HG

Administrative Core

$816,220
Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P30 · FY2022 · AG

Core 3: Drug Discovery and Development Core

$815,978
Mark J Suto · University Of Alabama At Birmingham · U54 · FY2018 · ES

Translational Studies of the Histone Deacetylase Inhibitor Romidepsin

$815,865
Susan Bates · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Using geroscience to understand and treat Alzheimer's disease

$815,791
Pamela Anne Maher · Salk Institute For Biological Studies · R01 · FY2021 · AG

Clinical Pharmacology Training Program

$815,600
Walter K. Kraft · Thomas Jefferson University · T32 · FY2022 · GM

GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease

$815,581
D. Martin Watterson · Northwestern University At Chicago · U01 · FY2025 · AG

De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity

$815,399
James E Kirby · Beth Israel Deaconess Medical Center · R01 · FY2020 · AI

Neurobehavioral Relations in Senescent Hippocampus

$815,314
Carol A. Barnes · University Of Arizona · R01 · FY2016 · AG